Patient Support Line 1-844-638-7222, Monday-Friday, 8:00 AM – 8:00 PM ET, excluding holidays.
PLUVICTO—now available for PSMA+ mCRPC before chemotherapy
If you’ve had hormone therapy, it may be time for PLUVICTO. Learn more about eligibility by clicking the link below.
About
mCRPC
Considering your next mCRPC treatment
There is a lot to process when hearing your, or a loved one’s, prostate cancer has spread.
About mCRPC: metastatic Castration-Resistant Prostate Cancer
There are different types of prostate cancer that you may have heard of:
Prostate cancer that has spread outside the prostate is called metastatic
Prostate cancer that is no longer responding to hormone treatment that lowers testosterone is called castration-resistant
When your cancer is metastatic and castration-resistant, it is called mCRPC.
If you have mCRPC, you may also be PSMA+ (prostate-specific membrane antigen positive)
You can find out if you are PSMA+ with a PSMA-PET scan
A PSMA-PET scan is an imaging test that allows your doctor to check for PSMA+ cells, including prostate cancer cells, in your body.